140 related articles for article (PubMed ID: 26275245)
21. Distribution and pathological features of pancreatic, ampullary, biliary and duodenal cancers resected with pancreaticoduodenectomy.
Chandrasegaram MD; Chiam SC; Chen JW; Khalid A; Mittinty ML; Neo EL; Tan CP; Dolan PM; Brooke-Smith ME; Kanhere H; Worthley CS
World J Surg Oncol; 2015 Feb; 13():85. PubMed ID: 25890023
[TBL] [Abstract][Full Text] [Related]
22. Ampullary cancer.
Heinrich S; Clavien PA
Curr Opin Gastroenterol; 2010 May; 26(3):280-5. PubMed ID: 20168227
[TBL] [Abstract][Full Text] [Related]
23. Prevalence and spectrum of pathogenic germline variants in intestinal and pancreatobiliary type of ampullary cancer.
Kumari N; Singh RK; Mishra SK; L R; Mohindra S; Krishnani N
Pathol Res Pract; 2021 Jan; 217():153309. PubMed ID: 33341547
[TBL] [Abstract][Full Text] [Related]
24. Clinical, morphologic, and immunophenotypic characteristics of ampullary carcinomas with an emphasis on SMAD4 expression.
Alkhasawneh A; Duckworth LV; George TJ; Desai NV; Sommerfeld AJ; Lu X; Toro TZ
J Gastrointest Oncol; 2016 Dec; 7(6):974-981. PubMed ID: 28078121
[TBL] [Abstract][Full Text] [Related]
25. Factors predicting survival and pathological subtype in patients with ampullary adenocarcinoma.
Okano K; Oshima M; Yachida S; Kushida Y; Kato K; Kamada H; Wato M; Nishihira T; Fukuda Y; Maeba T; Inoue H; Masaki T; Suzuki Y
J Surg Oncol; 2014 Aug; 110(2):156-62. PubMed ID: 24619853
[TBL] [Abstract][Full Text] [Related]
26. Immunophenotyping of ampullary carcinomata allows for stratification of treatment specific subgroups.
Leo JM; Kalloger SE; Peixoto RD; Gale NS; Webber DL; Owen DA; Renouf D; Schaeffer DF
J Clin Pathol; 2016 May; 69(5):431-9. PubMed ID: 26500334
[TBL] [Abstract][Full Text] [Related]
27. The expression of matrix metalloproteinases in intrahepatic cholangiocarcinoma, hilar (Klatskin tumor), middle and distal extrahepatic cholangiocarcinoma, gallbladder cancer, and ampullary carcinoma: role of matrix metalloproteinases in tumor progression and prognosis.
Kirimlioğlu H; Türkmen I; Başsüllü N; Dirican A; Karadağ N; Kirimlioğlu V
Turk J Gastroenterol; 2009 Mar; 20(1):41-7. PubMed ID: 19330734
[TBL] [Abstract][Full Text] [Related]
28. Endocrine cells in ampullary carcinoma.
Kamisawa T; Tu Y; Egawa N; Tsuruta K; Okamoto A; Funata N
J Hepatobiliary Pancreat Surg; 2009; 16(3):322-7. PubMed ID: 19214369
[TBL] [Abstract][Full Text] [Related]
29. Does ampullary carcinoma arise from distended glands in the papilla of Vater?
Sonoue H; Suda K; Nobukawa B; Abe H; Arakawa A; Hirai S; Matsumoto T
J Hepatobiliary Pancreat Surg; 2008; 15(2):161-8. PubMed ID: 18392709
[TBL] [Abstract][Full Text] [Related]
30. Neoplasms of the ampulla of vater with concurrent pancreatic intraductal neoplasia: a histological and molecular study.
Agoff SN; Crispin DA; Bronner MP; Dail DH; Hawes SE; Haggitt RC
Mod Pathol; 2001 Mar; 14(3):139-46. PubMed ID: 11266517
[TBL] [Abstract][Full Text] [Related]
31. [Results of surgical treatment in ampullary and pancreatic carcinoma and its prognostic parameters after R0-resection].
Ridwelski K; Meyer F; Schmidt U; Lippert H
Zentralbl Chir; 2005 Aug; 130(4):353-61. PubMed ID: 16103961
[TBL] [Abstract][Full Text] [Related]
32. Expression of MUC1 and MUC2 in ampullary cancer.
Moriya T; Kimura W; Hirai I; Takasu N; Mizutani M
Int J Surg Pathol; 2011 Aug; 19(4):441-7. PubMed ID: 21700631
[TBL] [Abstract][Full Text] [Related]
33. The clinicopathologic and immunohistochemical characteristics of ampulla of Vater carcinoma: the intestinal type is associated with a better prognosis.
Roh YH; Kim YH; Lee HW; Kim SJ; Roh MS; Jeong JS; Jung GJ
Hepatogastroenterology; 2007 Sep; 54(78):1641-4. PubMed ID: 18019683
[TBL] [Abstract][Full Text] [Related]
34. The use of histopathological subtyping in patients with ampullary cancer: a nationwide analysis.
de Bakker J; Sommeijer D; Besselink M; Kazemier G; van Grieken N
World J Surg Oncol; 2022 Dec; 20(1):406. PubMed ID: 36566267
[TBL] [Abstract][Full Text] [Related]
35. Expression of the caudal-type homeodomain transcription factors CDX 1/2 and outcome in carcinomas of the ampulla of Vater.
Hansel DE; Maitra A; Lin JW; Goggins M; Argani P; Yeo CJ; Piantadosi S; Leach SD; Biankin AV
J Clin Oncol; 2005 Mar; 23(9):1811-8. PubMed ID: 15774774
[TBL] [Abstract][Full Text] [Related]
36. Clinical significance of MUC1, MUC2 and CK17 expression patterns for diagnosis of pancreatobiliary arcinoma.
Yang HS; Tamayo R; Almonte M; Horten B; DaSilva M; Gangi M; Vazquez E; Joseph D; Okamoto P; Scholl T
Biotech Histochem; 2012 Feb; 87(2):126-32. PubMed ID: 21438791
[TBL] [Abstract][Full Text] [Related]
37. Expression of the GLUT1 glucose transporter and p53 in carcinomas of the pancreatobiliary tract.
Sung JY; Kim GY; Lim SJ; Park YK; Kim YW
Pathol Res Pract; 2010 Jan; 206(1):24-9. PubMed ID: 19819644
[TBL] [Abstract][Full Text] [Related]
38. The expression of matrix metalloproteinases-2 and -9 and their tissue inhibitor 2 in pancreatic ductal and ampullary carcinoma and their relation to angiogenesis and clinicopathological parameters.
Giannopoulos G; Pavlakis K; Parasi A; Kavatzas N; Tiniakos D; Karakosta A; Tzanakis N; Peros G
Anticancer Res; 2008; 28(3B):1875-81. PubMed ID: 18630474
[TBL] [Abstract][Full Text] [Related]
39. The histopathologic type of the periampullary tumors. Is it important for survival?
Georgescu SO; Neacşu CN; Vintilă D; Popa P; Florea N; Mihailovici MS
Chirurgia (Bucur); 2009; 104(6):697-700. PubMed ID: 20187467
[TBL] [Abstract][Full Text] [Related]
40. Prognosis of ampullary cancer based on immunohistochemical type and expression of osteopontin.
Zhao XQ; Dong JH; Zhang WZ; Liu Z
Diagn Pathol; 2011 Oct; 6():98. PubMed ID: 21992455
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]